Lebenthal Wealth Advisors’s Elevance Health ELV Stock Holding History

Lebenthal Wealth Advisors’s Portfolio ELV Stock Details ELV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q2	$359K	Buy	+2,732	New	+$374K	1.06%	39

Other funds holding ELV

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Barrow, Hanley, Mewhinney & Strauss Dallas, Texas $30.5B AUM 29.95% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Nordea Investment Management Stockholm, Sweden $107B AUM 24.58% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

BlackRock Advisors Wilmington, Delaware $98.8B AUM 15.8% 1-Year Est. Return

Lebenthal Wealth Advisors's ELV Position: Q2 2016 in Review

Lebenthal Wealth Advisors opened a new position in Elevance Health (ELV) in Q2 2016: 2,732 shares worth $359K. The stake represents 1.06% of the portfolio and ranks #39 among its holdings.

759 funds tracked by Wall St. Rank hold ELV as of Q2 2016.

Lebenthal Wealth Advisors held 2,732 shares of Elevance Health worth $359K as of Q2 2016.
Elevance Health was a new Lebenthal Wealth Advisors position in Q2 2016.
Elevance Health made up 1.06% of Lebenthal Wealth Advisors's portfolio in Q2 2016, its #39 holding.
759 funds tracked by Wall St. Rank held Elevance Health as of Q2 2016.

Based on Lebenthal Wealth Advisors's 13F filing for Q2 2016, filed 11 Aug 2016.